Liquidia Corporation Common Stock

LQDANASDAQ • USD
56.46 USD
↘ 0.95 (1.65%)🟢LIVE (AS OF 11:26 AM EST)
🟢Market: OPEN

Liquidia Corporation Common Stock (LQDA) trades at $56.46 per share. There is a divergence between signals — technical indicators rate "Buy" but underlying fundamentals lean "Sell". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (370.3%) and a bearish Death Cross on the long-term moving averages. LQDA is fairly valued relative to its sector peers based on current multiples.

Technical & fundamental data as of Nov 13, 2026.

Open?$56.75
High?$58.02
Low?$55.75
Prev. Close?$57.41
Volume?473.7K
Avg. Volume?4.4M
VWAP?$57.11
Rel. Volume?0.11x
Bid / Ask
Bid?$49.34 × 100
Ask?$65.04 × 100
Spread?$15.70
Midpoint?$57.19
Valuation & Ratios
Market Cap?5.2B
Shares Out?90.1M
Float?66.1M
Float %?73.8%
P/E Ratio?N/A
P/B Ratio?-203.39
EPS?-$1.05
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also conducting studies on L606, an investigational, liposomal formulation of treprostinil.
Employees
216
Market Cap
5.2B
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2018-07-26
Address
419 DAVIS DRIVE, SUITE 100
MORRISVILLE, NC 27560
Phone: 919.328.4400
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+2/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
80
Momentum?
97
Short Sent.?
42
Piotroski F-Score?2/9Weak
Altman Z-Score?3.34Safe
Confidence?55%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?26.50%Squeeze Risk
Short Interest?17.5M
Days to Cover?5.3
Free Float66.1M
Avg Daily Volume3.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?1.02Adequate
Quick Ratio?0.96Weak
Cash Ratio?0.68Adequate
Debt/Equity?-6.37Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
S&P
97
-203.39CHEAP▾
P/S?
Peers
100
S&P
12
8.32HIGH▾
P/FCF?
Peers
100
S&P
63
17.8CHEAP▾
EV/EBITDA?
Peers
100
S&P
39
16.8FAIR▾
EV/Sales?
Peers
100
S&P
17
7.94HIGH▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
370.3%STRONG▾
ROA?
S&P
3
-13.8%WEAK▾
Cash Flow & Enterprise
FCF?$291.2M
Enterprise Value?$4.9B
Fundamentals ratios updated end of day